Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData, Phase II drugs for Non-Small Cell Lung Cancer ...

Amgen and AstraZeneca have said their severe asthma therapy Tezspire could have ... Trends towards improved outcomes were also seen with the drug on lung function scores and patient-reported ...

Dupilumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase III for Bullous Pemphigoid. According to GlobalData, Phase III drugs for Bullous Pemphigoid does not have ...

Researchers reported that a lung MRI technique that uses inhaled gas can identify early patchy lung defects in patients with ...

Jan. 21, 2025 — A new study found that pregnant women are regularly excluded from clinical drug trials that test for safety, raising concerns for the efficacy of these medications for maternal ...

Asthma, chronic obstructive pulmonary disease (COPD) and lung cancer cause extensive mortality and morbidity worldwide. However, the current state-of-the-art diagnosis and management schemes of ...

Looking for the name of Marcel Proust on search engines, it seems that the centenary of his death (1922) has gone unnoticed by medical doctors. Several essays on his illness have already been ...

More than five million people in the UK suffer with asthma. Asthma + Lung UK, external have said that humidity and thunderstorms can cause an 'unseasonal spike' in asthma-related A&E visits ...

Asthma is usually considered a separate respiratory disease, but sometimes, it’s mistaken for COPD. Both are lung diseases that can have many of the same symptoms, including shortness of breath ...

A systematic review and meta-analysis indicated that omalizumab significantly improved lung function and asthma control while ... switched from mepolizumab to dupilumab experienced significant ...

For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges. We spoke with Dr Andy Whittamore, GP and clinical lead at Asthma + Lung UK ...